Published in Medical Devices and Surgical Technology Week, June 28th, 2009
"Current mealtime insulin therapies, while accepted as an effective means to control glucose levels, have several limitations,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.